Fountain Therapeutics Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
17
- Latest Deal Type
-
Series A2
- Latest Deal Amount
-
$15M
- Investors
-
7
Fountain Therapeutics General Information
Description
Operator of a biotechnology company designed to treat age-related diseases by reversing cellular age. The company's therapeutics offer a transformative model of aging that re-creates many of the complex hallmark features and combines the powerful cellular model with artificial intelligence and computer vision to develop a disruptive, unbiased platform for the identification of novel targets and potential therapeutics, enabling doctors to treat diseases associated with aging.
Contact Information
Website
www.fountainml.comCorporate Office
- 681 Gateway Boulevard
- San Francisco, CA 94080
- United States
Corporate Office
- 681 Gateway Boulevard
- San Francisco, CA 94080
- United States
Fountain Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Early Stage VC (Series A2) | 15-Nov-2021 | $15M | Completed | Generating Revenue | ||
| 3. Early Stage VC (Series A1) | 19-Feb-2020 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series A) | 07-May-2018 | $5M | $5M | Completed | Pre-Clinical Trials | |
| 1. Accelerator/Incubator | 01-Jan-2018 | Completed | Pre-Clinical Trials |
Fountain Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A2 | ||||||||
| Series A-1 | ||||||||
| Series A | 7,998,720 | $0.001000 | 8% | $0.63 | $0.63 | 1x | $0.63 | 18.54% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Fountain Therapeutics Comparisons
Industry
Financing
Details
Fountain Therapeutics Competitors (3)
One of Fountain Therapeutics’s 3 competitors is BioAge Labs, a Formerly VC-backed company based in Emeryville, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| BioAge Labs | Formerly VC-backed | Emeryville, CA | ||||
| Recyte Therapeutics | Formerly VC-backed | Alameda, CA | ||||
| Unity Biotechnology | Formerly VC-backed | South San Francisco, CA |
Fountain Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Fountain Therapeutics Patents
Fountain Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025193959-A1 | Methods & compositions for treating dermal atrophy | Pending | 13-Mar-2024 | ||
| US-20240156825-A1 | Use of selective vegfr2 and fgfr1 inhibitors | Pending | 10-Jun-2022 | ||
| WO-2023240271-A1 | Use of vegfr2 and fgfr1 inhibitors in therapy | Inactive | 10-Jun-2022 | ||
| US-20220237930-A1 | Cell age classification and drug screening | Inactive | 21-Aug-2019 | ||
| WO-2021035097-A1 | Cell age classification and drug screening | Inactive | 21-Aug-2019 | G06V20/698 |
Fountain Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Fountain Therapeutics Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Alexandria Venture Investments | Venture Capital | Minority | ||
| Eli Lilly and Company Foundation | Limited Partner | Minority | ||
| Nan Fung Life Sciences | Venture Capital | Minority | ||
| R42 Group | Venture Capital | Minority | ||
| Eshelman Ventures | Venture Capital | Minority |
Fountain Therapeutics FAQs
-
When was Fountain Therapeutics founded?
Fountain Therapeutics was founded in 2018.
-
Where is Fountain Therapeutics headquartered?
Fountain Therapeutics is headquartered in San Francisco, CA.
-
What is the size of Fountain Therapeutics?
Fountain Therapeutics has 17 total employees.
-
What industry is Fountain Therapeutics in?
Fountain Therapeutics’s primary industry is Drug Discovery.
-
Is Fountain Therapeutics a private or public company?
Fountain Therapeutics is a Private company.
-
What is the current valuation of Fountain Therapeutics?
The current valuation of Fountain Therapeutics is .
-
What is Fountain Therapeutics’s current revenue?
The current revenue for Fountain Therapeutics is .
-
How much funding has Fountain Therapeutics raised over time?
Fountain Therapeutics has raised $26M.
-
Who are Fountain Therapeutics’s investors?
Alexandria Venture Investments, Eli Lilly and Company Foundation, Nan Fung Life Sciences, R42 Group, and Eshelman Ventures are 5 of 7 investors who have invested in Fountain Therapeutics.
-
Who are Fountain Therapeutics’s competitors?
BioAge Labs, Recyte Therapeutics, and Unity Biotechnology are competitors of Fountain Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
